Real-world pharmacovigilance analysis of depression associated with antineoplastic agents.

Cancer remains a major global health threat. Although antineoplastic agents have significantly improved survival outcomes, growing evidence indicates that they may also induce neuropsychiatric adverse events (AEs), particularly depressive symptoms. S…

Preview only. Read the full abstract at the source